by University of Cambridge Credit: Pixabay/CC0 Public DomainSARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies. A University of Cambridge-led study identifies the protein...
by Trinity College Dublin Credit: Unsplash/CC0 Public Domain A team of scientists from Trinity College Dublin and investigators from FutureNeuro has announced a major discovery with profound importance for our understanding of brain fog and cognitive decline seen in some patients with long COVID. The work appears in Nature Neuroscience.In the months after the emergence of...
by University of Michigan Credit: Pixabay/CC0 Public DomainMany patients continue to struggle in the wake of the pandemic as they grapple with ongoing symptoms triggered by COVID-19 infection, a condition commonly known as long COVID. However, the onset of symptoms such as brain fog, fatigue, headache, and other types of pain is not unique to COVID...
Sara Novak Brain fog is one of the most common, persistent complaints in patients with long COVID. It affects as many as 46% of patients who also deal with other cognitive concerns like memory loss and difficulty concentrating. Now, researchers believe they know why. A new study has found that these symptoms may be the...
by Gillian Rutherford, University of Alberta Altered metabolomic profile in SARS-CoV-2 infected individuals. Credit: Frontiers in Immunology (2024). DOI: 10.3389/fimmu.2024.1341843A University of Alberta research team brings together immunologists, virologists, rheumatologists and metabolomics experts in an effort to discover exactly what is ailing the sickest long COVID patients and find treatments for them. In research recently published...
By Sarah Willey The study discovered similarities in immune system dysfunction as a potential biomarker among people living with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, PhD, and Anna Gil, PhD, discovered similarities in immune system dysfunction as a potential biomarker among people living...
By Sarah Willey The study discovered similarities in immune system dysfunction as a potential biomarker among people living with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, PhD, and Anna Gil, PhD, discovered similarities in immune system dysfunction as a potential biomarker among people living...
Sara Novak With a number of large-scale clinical trials underway and researchers on the hunt for new therapies, long COVID scientists are hopeful that this is the year patients — and doctors who care for them — will finally see improvements in treating their symptoms. Here are five bold predictions — all based on encouraging...
Solarina Ho The COVID-19 pandemic may no longer be a global public health emergency, but millions continue to struggle with the aftermath: Long COVID. New research and clinical anecdotes suggest that certain individuals are more likely to be afflicted by the condition, nearly 4 years after the virus emerged. People with a history of allergies,...
by University of Leeds Heart Rate Variability Biofeedback (HRV-B) using a breathing technique and chest strap for real time HRV monitoring. Credit: Wikimedia commons, reprinted under CC BY-SA 3.0 license. EliteHRV screenshot from Wikimedia commons, reprinted under CC BY-SA 4.0 license. Advances in Rehabilitation Science and Practice (2024). DOI: 10.1177/27536351241227261Simple breathing exercises done twice daily while...
